NCT07050225

Brief Summary

The goal of this clinical trial is to evaluate whether a digital cognitive training program can reduce symptoms of ADHD, improve executive functioning, and decrease problematic internet use in adults aged 18-65 with a diagnosis of moderate to severe ADHD. The main questions it aims to answer are: Can digital cognitive training improve executive function, and ADHD symptoms in adults with ADHD? Does digital cognitive training reduce problematic internet use in this population? Researchers will compare the digital cognitive training intervention group to a non-cognitive training digital platform to see if the training leads to greater improvements in cognitive and behavioral outcomes. Participants will: Complete an 11-week digital cognitive training program (3, 1-hour sessions/week) or placebo intervention (3, 1-hour sessions/week) Attend baseline, midpoint, and post-intervention assessments Participate in weekly check-ins to monitor engagement and tolerability

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
29 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

July 22, 2025

Status Verified

June 1, 2025

Enrollment Period

5 months

First QC Date

June 6, 2025

Last Update Submit

July 17, 2025

Conditions

Keywords

ADHDAttention Deficit Hyperactivity DisorderProblematic Internet UsePIUCognitive Training InterventionExecutive FunctioningAdult ADHDADHD SymptomsDigital HealthAdjunct TherapyHyperactivityAttention

Outcome Measures

Primary Outcomes (2)

  • Number of participants who prematurely withdraw from the study protocol

    Tolerability of the digital cognitive training intervention will be assessed by calculating the number of participants who discontinue participation before completing the full 11-week study protocol. Premature withdrawal will be defined as any participant who discontinues the intervention and/or does not complete post-treatment assessments.

    From enrollment to the end of treatment at 11 weeks

  • The feasibility of digital cognitive training on ADHD symptoms in adults diagnosed with ADHD of moderate-severe severity

    Feasibility will be evaluated based on the number of people who contact the study team, percent of people who contact who are eligible, and percent of eligible participants who enroll. Percent of participants lost to follow-up will be a key determinant of feasibility, as well as number of completers.

    From enrollment to the end of treatment at 11 weeks

Secondary Outcomes (6)

  • The effect of digital cognitive training on ADHD symptoms in adults diagnosed with ADHD of moderate-severe severity

    From enrollment to the end of treatment at 11 weeks

  • The effects of digital cognitive training on problematic internet use in adults diagnosed with ADHD of moderate-severe severity

    From enrollment to the end of treatment at 11 weeks

  • The effects of digital cognitive training on visual processing and working memory in adults diagnosed with ADHD of moderate-severe severity

    From enrollment to the end of treatment at 11 weeks

  • The effects of digital cognitive training on cognitive flexibility in adults diagnosed with ADHD of moderate-severe severity

    From enrollment to the end of treatment at 11 weeks

  • The effects of digital cognitive training on working memory in adults diagnosed with ADHD of moderate-severe severity

    From enrollment to the end of treatment at 11 weeks

  • +1 more secondary outcomes

Other Outcomes (3)

  • Changes on symptoms of anxiety

    From enrollment to the end of treatment at 11 weeks

  • Changes on symptoms of depression

    From enrollment to the end of treatment at 11 weeks

  • Changes in quality of life

    From enrollment to the end of treatment at 11 weeks

Study Arms (2)

Digital Cognitive Training

EXPERIMENTAL

Participants randomized to the intervention group will receive 1-hour cognitive training sessions three times weekly for 10 weeks. The digital cognitive training platform will consist of personalized gamified cognitive tasks that target individual cognitive deficits associated with ADHD including attention, impulsivity, working memory, and cognitive flexibility.

Other: Digital Cognitive Training

Digital Non-cognitive Training Intervention

PLACEBO COMPARATOR

Participants will use a control gamified computer platform matched for time but lacking cognitive training components. Participants will engage in this activity for 1 hour three times a week for a duration of 10 weeks.

Other: Digital Non-cognitive Training Intervention

Interventions

This digital cognitive training program uses gamified tasks in order to enhance cognitive skills in an engaging manner using machine learning AI algorithms to target the intervention to individual cognitive skill deficits. It consists of personalized gamified cognitive tasks that target individual cognitive deficits associated with ADHD including attention, impulsivity, working memory, and cognitive flexibility.

Digital Cognitive Training

This is a gamified computer platform lacking cognitive training components.

Digital Non-cognitive Training Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must provide informed consent and agree to comply with study protocols for the duration of the study.
  • Participants must be fluent in speaking and reading English and able to complete rating scales and assessments.
  • Participants must be adults aged 18-65 years.
  • Participants must have a clinical diagnosis of ADHD based on DSM-5 Criteria, as confirmed by the Mini Neuropsychiatric interview.
  • Participants being treated with pharmacotherapy must be stable and on a consistent dose for at least 6 weeks prior to study entry.
  • Participants must have access to a computer capable of running the cognitive training platform.
  • Participants must be comfortable operating a computer and be able to log on to the platform without assistance.

You may not qualify if:

  • Exclude individuals who meet DSM-5 criteria for psychiatric conditions such as borderline personality disorder, schizophrenia, severe depression, or other psychotic disorders as well as neurological conditions such as epilepsy, dementia, and amnesia, that may interfere with cognitive training.
  • Exclude participants with active substance use disorders.
  • Exclude participants receiving behavioral therapy or undergoing similar cognitive training programs for ADHD and/or PIU.
  • Exclude individuals with severe visual, auditory, or motor impairments that affect the ability to perform the digital cognitive training intervention.
  • Exclude participants who are uncomfortable using applications or required technology.
  • Exclude participants who have changed their treatment regimen in the last 6 weeks.
  • Exclude participants who are not fluent in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivitySpasm

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2025

First Posted

July 3, 2025

Study Start

August 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

July 22, 2025

Record last verified: 2025-06